As obligate intracellular parasites, viruses frequently utilize the cytoskeleton for entry and intracellular transport (28, 32) . The human immunodeficiency virus (HIV-1) appears to be one of the pathogens that rely on the host cytoskeleton, both actin and microtubules, to initiate infection (14, 28, 32) . It has been suggested that the cortical actin is directly involved in viral gp120-mediated CD4-CXCR4 clustering, which may facilitate viral entry (7, 18, 19, 29, 33, 41) . After membrane fusion, HIV-1 encounters the dense meshwork of the cortical actin that appears to be important for viral reverse transcription (9, 47, 48) . The cortical actin itself may also represent a barrier for viral intracellular migration (47, 48) , particularly in noncycling resting CD4 T cells, where the actin cortex is less dynamic (48) . HIV-1 may utilize both viral proteins, such as gp120 and Nef (1, 10, 11, 37, 48) , or host factors such as cofilin and LIMK1 to remodel cortical actin, thereby allowing HIV-1 to overcome this restriction (37, 48) . Following migration across the actin cortex, the virus has to travel through the cytoplasm for nuclear localization. Because of the high viscosity of the cytoplasm, it has been suggested that HIV-1 may utilize the microtubule network for intracellular trafficking (4, 27, 50) . In general, intracellular movement of macromolecules or organelles within the cytoplasm requires actin microfilaments for short-distance travel and microtubules for long-distance migration. Indeed, using fluorescently labeled HIV-1 particles, multiple studies have shown that the preintegration complex (PIC) of HIV-1 tracks along microtubules and accumulates in the microtubule-organizing center for nuclear localization (4, 27, 50) . Nevertheless, concerns have been raised regarding whether these microscopy experiments distinguish replication-competent viruses from mostly noninfectious particles (38) . In addition, these previous imaging studies were often undertaken using adherent, immortalized cell lines that have extensive microtubule networks compared to those of primary CD4 T cells. It is interesting to note that the relatively thin cytoplasm in T cells may require only short-distance travel for viral nuclear localization (Fig. 1A) . Thus, the biological significance of HIV tracking along microtubules remains a subject of debate. In this article, using pharmacological modulators of microtubules, we investigated the potential role of microtubules in the initiation of HIV-1 infection of T cells.
To provide direct evidence for the involvement of microtubules in the early steps of HIV infection, we used multiple microtubule modulators, such as paclitaxel (originally called taxol; TX), vinblastine (VB), colchicine (CN), and nocodazole (ND) to stabilize or disrupt microtubules in human T cells. TX is a complex diterpene initially identified in screens of compounds with anticancer activity (42) . TX binds and stabilizes microtubule polymers, thereby preventing microtubule dissociation (36) . VB is a plant alkaloid that binds to tubulin and prevents microtubule assembly at concentrations at or below 10 M (21, 24, 34, 44) . CN binds to tubulin and blocks microtubule formation by stimulating the intrinsic GTPase activity of tubulin (5, 25) . The tubulin dimer must be bound to GTP for normal microtubule assembly to occur. Finally, ND disrupts microtubules by binding to ␤-tubulin and prevents the formation of one of the two interchain disulfide bridges (26) .
To verify that these microtubule modulators were in fact disturbing the microtubule network at the applied dosages, we tested them on a human indicator T cell line, Rev-CEM (45) . We also tested these drugs on primary human resting CD4 T cells that were purified from peripheral blood by negative depletion (46) . For comparison, adherent HeLa cells cultured on poly-L-lysine-coated coverslips were treated in an identical manner. Cells were rested overnight and then treated with the drugs for 2.5 h at the following doses: 1 M TX, 1 and 10 M VB, 10 and 100 M CN, and 10 and 100 M ND (6, 12, 17) . As a control, cells were treated in the identical manner with the solvent dimethyl sulfoxide. (DMSO). After treatments, cells were fixed, permeabilized (Cytofix/Cytoperm, Perm/Wash buffer; BD Biosciences, San Jose, CA), and then stained for confocal microscopy of the microtubule networks. For microtubule staining, cells were incubated with a biotinylated anti-␣-tubulin antibody (clone 10D8; Biolegend, San Diego, CA), followed by staining with Alexa Fluor 594-labeled streptavidin (Invitrogen, Carlsbad, CA). As shown in Fig. 1B , an extensive microtubule network was observed in HeLa cells. In contrast, Rev-CEM and resting CD4 T cells exhibited uniform round shapes with low levels of microtubule staining. As expected, TX treatment did not result in robust changes in cell shape or the microtubule network of HeLa, Rev-CEM, or resting CD4 T cells. The preservation of microtubule networks was expected in TX-treated cells because TX binds and stabilizes existing microtubule polymers, thereby preventing microtubule dissociation (36) . For VB at both dosages (1 and 10 M), a complete collapse of the microtubule network was observed, with microtubules remaining only near the nucleus in HeLa cells. CN has a mechanism of action similar to that of VB in that it prevents microtubule assembly. In 10 and 100 M CNtreated HeLa cells, a definite reduction in the number and branching of microtubules was observed. ND disrupts microtubules by binding to ␤-tubulin and prevents the formation of one of the two interchain disulfide bridges (26) . Treatment of HeLa cells with 10 or 100 M ND resulted in a loss of the elongated microtubule network; it was replaced with shortened microtubules that were condensed and spiral shaped.
For human T cells, treatment of Rev-CEM cells with VB, CN, and ND resulted in cell shape changes characterized by polarized microtubule staining, with cells exhibiting a flattened leading edge and a retracting edge. Treatment of resting CD4 T cells with these drugs also resulted in morphological changes similar to those in Rev-CEM cells but to a lesser degree. This was expected, as resting CD4 T cells have large nuclei, little cytoplasm, and very low levels of microtubule staining.
Next, we tested the requirement for microtubule integrity in the early phases of HIV-1 infection of T cells. Given the high dosages of the drugs used and the expected cytotoxicity, we used the Rev-dependent green fluorescent protein (GFP) indicator T cell line Rev-CEM (45) to measure the inhibition of HIV-1 infection instead of simply using a p24 enzyme-linked immunosorbent assay (ELISA), which by itself is not able to distinguish between general drug cytotoxicity and HIV-specific inhibition (49) . Additional advantages of using the cell line Rev-CEM are its high specificity and nonresponsiveness to non-HIV induction. This is distinguishably different from long terminal repeat (LTR)-driving reporter cells that are often leaky and highly responsive to agents stimulating cellular activities. It has been known that mi- crotubule inhibitors such as TX and VB are capable of inducing the expression of reporter genes driven by the HIV-LTR promoter (2, 39). However, when tested on Rev-CEM cells, these drugs alone were not capable of stimulating GFP expression (Fig.  2) , demonstrating the high stringency of Rev-CEM cells for HIVdependent reporter expression.
To measure the inhibition of HIV-1 infection by microtubule modulators, Rev-CEM cells were pretreated with the drugs, either for 30 min (Fig. 3B) or for 2.5 h (Fig. 3C) , and then infected with HIV-1 for 2 h in the continuous presence of the drugs. Following infection, cell-free virus and the drugs were washed away. Cells were resuspended in fresh medium and cultured in the absence of drugs for 2 days, at which point the GFP-positive cells were measured by flow cytometry. As shown in Fig. 3B , treatment of Rev-CEM cells with TX resulted in an almost 2-fold (from 4.6% to 8.8%) enhancement of HIV infection compared to the results with untreated, HIV- 1-infected cells. Surprisingly, treatment of Rev-CEM cells with VB also slightly enhanced HIV-1 infection, despite considerable collapse of the microtubule network and high drug cytotoxicity. CN treatment did not significantly inhibit or enhance HIV-1 infection, whereas ND treatment slightly enhanced HIV-1 infection. A similar lack of inhibition was also seen when cells were pretreated for longer time (2.5 h) (Fig. 3C) . Based on these data, it appears that during the first 2 h of HIV-1 infection, intact microtubules may not be required for productive HIV-1 infection of transformed T cells. We further investigated whether these microtubule modulators would affect HIV-1 latent infection of resting CD4 T cells in blood. Cells were similarly pretreated with the drugs and then infected with HIV-1 for 2 h in the presence of the drugs (Fig. 4A) . Cell-free virus and the drugs were washed away following infection. Infected cells were resuspended in fresh medium and cultured for 5 days in the absence of the drugs and stimulation. During this period, no viral replication occurs. However, HIV replication remains inducible upon T cell activation. Cells were subsequently activated at day 5 with CD3/ CD28 bead stimulation (4 beads per cell), and HIV replication was monitored by extracellular p24 release. As shown in Fig.  4B and C, none of the microtubule modulators except 100 M CN inhibited HIV-1 latent infection of resting CD4 T cells. The fact that 100 M CN inhibited HIV-1 infection probably resulted from its general cytotoxicity at such a high dosage rather than from specific microtubule disruption, since 10 M CN had no effect on HIV-1 latent infection of resting T cells despite its ability to disrupt microtubules. Treatment with both dosages of VB and with 10 M ND actually slightly enhanced HIV-1 infection, although the reason is unknown. Similar enhancements of HIV-1 replication by TX, VB, and ND were also observed in the infection of Rev-CEM cells (Fig. 3B) . Perhaps microtubule modulation promotes intracellular survival of HIV-1 that enters via endocytosis. HIV-1 virions which enter cells through the endocytic pathway are usually destroyed in late endosomes. Microtubule disruption or stabilization could block the transport of endosome carrier vesicles to late endosomes (3). It is known that treatment of cells with pharmacological agents that block viral degradation in late endosomes greatly enhances HIV infection (15) .
The lack of inhibition of HIV infection by microtubule drugs could result from possible reassembly of the microtubule network following virus and drug removal. However, it has been shown that early signals mediated from the viral envelope protein play a critical role in viral nuclear migration (48) . A significant fraction of viral DNA migrated into the nucleus of resting T cells during the first 2 h, concurrent with the gp120-mediated signaling events (48) . When input viruses were removed following infection, viral nuclear migration was decreased in the absence of gp120 signaling, leading to the gradual decay of residual viral DNA (48, 49) . Thus, even with possible reassembly of the microtubule network at a later time, viral nuclear migration may not occur in the absence of gp120 signaling.
For a comparison, we also identically treated resting CD4 T cells with an actin inhibitor, jasplakinolide (JP) (8) . In contrast to the general lack of inhibition of viral infection by microtubule inhibitors, JP effectively inhibited viral latent infection of resting CD4 T cells at 120 nM (Fig. 4D) (48) . These data suggest that intact microtubules may not be required, at least during the first 2 h of HIV-1 infection of resting CD4 T cells, whereas early actin dynamics are critical (9, 48) . Actin-dependent intracellular migration has been demonstrated recently in certain viruses such as the baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV). AcMNPV utilizes exclusively actin filaments, not microtubules, for nuclear migration (31) . In HIV-1 infection, multiple viral proteins in the preintegration complex (PIC) are known to directly interact with actin (13, 16, 22, 30, 35, 40, 43) , suggesting possible anchorage of PIC onto the cortical actin for reverse transcription and intracellular migration (9, 23, 47, 48) .
Although our study of the microtubule modulators does not appear to support an essential role of microtubules in the early phases of HIV infection of T cells, we do not exclude the importance of the microtubule network for late infection events, such as viral assembly, budding, and spread (20) . In addition, our data also do not exclude the involvement of microtubules in the infection of adherent cells such as macrophages, which have more extensive microtubule networks than CD4 T cells. 
